148 In the index

BPC-157 arginate BPC-A

A modified, more stable salt version of BPC-157. It shares the same weak evidence base as regular BPC-157 — mostly animal studies — with no dedicated human research of its own.

Also known as Arginate salt form, Bpc 157, Bpc-157, Bepecin, Bpc 15, pl-10, 8ED8NXK95P, RefChem:121176, Bpc157

Effects Heal

Routes Oral Subcutaneous

Legal status Research chemical

WADA Not listed

Molecular Structure of C₆₂H₉₈N₁₆O₂₂

Drag to rotate · scroll to zoom

Chemistry

Formula: C62H98N16O22
Molar mass: 1419.5
CAS: 137525-51-0
PubChem CID: 9941957
IUPAC name: (4S)-4-[(2-aminoacetyl)amino]-5-[(2S)-2-[(2S)-2-[(2S)-2-[[2-[[(2S)-6-amino-1-[(2S)-2-[[(2S)-1-[[(2S)-3-carboxy-1-[[(2S)-3-carboxy-1-[[(2S)-1-[[2-[[(2S)-1-[[(1S)-1-carboxy-2-methylpropyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxohexan-2-yl]amino]-2-oxoethyl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-5-oxopentanoic acid
InChIKey: HEEWEZGQMLZMFE-RKGINYAYSA-N

Reported dosing

User-reported

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose 250-500 mcg/day

Reported range 200-1000 mcg/day

Route Subcutaneous injection or oral

Frequency Once or twice daily

Duration 4-8 week course (unregulated use)

Marketed as a more stable salt form of BPC-157; underlying human safety and efficacy data is the same as standard BPC-157 — essentially none from controlled human trials.

Where this comes from Animal studies only (parent compound); user-reported/research-chemical vendor literature

There is no approved human dosing for this compound. The figures above are what users and vendors report, not what has been established as safe or effective. Treat them as a record of what is done, not as guidance.